Minister of Health: Indonesia contributes to Global Fund 15.5 million US dollars Minister of Health: Indonesia contributes to Global Fund 15.5 million US dollars

Minister of Health: Indonesia contributes to Global Fund 15.5 million US dollars

Minister of Health: Indonesia contributes to Global Fund 15.5 million US dollars  Jakarta (ANTARA) - The Indonesian government will contribute to funding global efforts to combat TB, HIV/AIDS, and malaria worth US$15.5 million in 2023-2025 through the Global Fund health partnership.  "Today, the Indonesian government has stepped forward for the first time not only as a recipient country, but also as a donor country for public and private partnerships," said Indonesian Health Minister Budi Gunadi Sadikin in a press release received in Jakarta, Saturday.  Of the total US$15.5 million contribution from Indonesia, US$10 million of which is a contribution from the State Revenue and Expenditure Budget (APBN).  While the rest is contributed by the pharmaceutical industry and foundations in Indonesia, such as Sinarmas with US$2 million, Kalbe with US$1.5 million, Paloma Foundation with US$1 million, and the Tanoto Foundation with US$1 million.  According to Budi, this contribution is a concrete step for Indonesia to prepare the agenda for the 2023 UN High Level Meeting on Tuberculosis (TB).  During his visit to New York, United States to fulfill the invitation to the Global Fund Seventh Replenishment Conference, Thursday (22/9), Budi said that Indonesia's investment is a form of implementation of health transformation, especially in the third and sixth pillars.  In the pillars of the transformation of the health resilience system, the funding will be used for the development of new TB drugs in the first line, as well as for the treatment of resistant TB patients, as well as TB vaccines.  This activity also supports the transformation of the sixth pillar of health transformation, namely Health Technology Transformation, specifically in building the capacity of genome sequencing laboratories for more accurate identification of viruses and bacteria, including diagnostic tools to detect TB.  The Global Fund raises and invests funds in a three-year cycle known as Replenishment.  This three-year approach was adopted in 2005 to allow for more stable and predictable financing for countries and to ensure the continued viability of the programme.  A total of 48 countries and more than 25 private sectors contributed to the replenishment of the Global Fund for the next three years, with a total contribution of US$ 14.25 billion.  Indonesia has contributed through Replenishment since 2014 through philanthropy in the country.  The Global Fund is a health development partner in Indonesia, especially in pursuing the target of eliminating HIV/AIDS, TB, Malaria.  Since 2003 to date, US$1.45 billion (Rp20.89 trillion) has been given to the Ministry of Health and the community, especially for programs to combat HIV/AIDS, TB and Malaria.  The Global Fund grant also supports the Government of Indonesia in dealing with COVID-19 through strengthening detection of genome sequencing in the period 2021-2023.

Jakarta (ANTARA) - The Indonesian government will contribute to funding global efforts to combat TB, HIV/AIDS, and malaria worth US$15.5 million in 2023-2025 through the Global Fund health partnership.

"Today, the Indonesian government has stepped forward for the first time not only as a recipient country, but also as a donor country for public and private partnerships," said Indonesian Health Minister Budi Gunadi Sadikin in a press release received in Jakarta, Saturday.

Of the total US$15.5 million contribution from Indonesia, US$10 million of which is a contribution from the State Revenue and Expenditure Budget (APBN).

While the rest is contributed by the pharmaceutical industry and foundations in Indonesia, such as Sinarmas with US$2 million, Kalbe with US$1.5 million, Paloma Foundation with US$1 million, and the Tanoto Foundation with US$1 million.

According to Budi, this contribution is a concrete step for Indonesia to prepare the agenda for the 2023 UN High Level Meeting on Tuberculosis (TB).

During his visit to New York, United States to fulfill the invitation to the Global Fund Seventh Replenishment Conference, Thursday (22/9), Budi said that Indonesia's investment is a form of implementation of health transformation, especially in the third and sixth pillars.

In the pillars of the transformation of the health resilience system, the funding will be used for the development of new TB drugs in the first line, as well as for the treatment of resistant TB patients, as well as TB vaccines.

This activity also supports the transformation of the sixth pillar of health transformation, namely Health Technology Transformation, specifically in building the capacity of genome sequencing laboratories for more accurate identification of viruses and bacteria, including diagnostic tools to detect TB.

The Global Fund raises and invests funds in a three-year cycle known as Replenishment.

This three-year approach was adopted in 2005 to allow for more stable and predictable financing for countries and to ensure the continued viability of the programme.

A total of 48 countries and more than 25 private sectors contributed to the replenishment of the Global Fund for the next three years, with a total contribution of US$ 14.25 billion.

Indonesia has contributed through Replenishment since 2014 through philanthropy in the country.

The Global Fund is a health development partner in Indonesia, especially in pursuing the target of eliminating HIV/AIDS, TB, Malaria.

Since 2003 to date, US$1.45 billion (Rp20.89 trillion) has been given to the Ministry of Health and the community, especially for programs to combat HIV/AIDS, TB and Malaria.

The Global Fund grant also supports the Government of Indonesia in dealing with COVID-19 through strengthening detection of genome sequencing in the period 2021-2023.

Post a Comment

Previous Post Next Post